X
14Jul

Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.

Jones Day | | Return|
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By: Jones Day
Source Url: https://www.jdsupra.com/legalnews/japan-tightens-foreign-direct-13774/

Related

Companies Remain In Suspense On AB 5 Independent Contractor Bill

Seyfarth Synopsis: The hotly contested AB 5 was put on hold, but is widely expected to be revived be...

Read More >

Proceed at Your Own Risk: Government Entitled to Strict Compliance with Plans and Specifications

In Appeal of Watts Constructors, LLC, the Armed Services Board of Contract Appeals (the “Board”) h...

Read More >

Gig Economy’s 7-Point Plan For Managing The COVID-19 Coronavirus Outbreak

Given that the gig economy is a relatively recent phenomenon, the industry has not yet experienced s...

Read More >

Breaking News: California Employers Get Temporary Relief From AB 51’s Attempted Arbitration Ban

AB 51 was signed into law on October 10, 2019, and purported to outlaw the use of mandatory arbitrat...

Read More >

[Event] International Women’s Day #EachforEqual – Advancing Women in Finance - March 5th, San Francisco, CA

Be a part of the conversation! Join us for our International Women's Day event, a solutions-oriented...

Read More >